Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000029798Phase 4Not yet recruiting
Phase 4, randomised trial of tranexamic acid in arthritis and rheumatoid arthritis (RA) (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: blood loss. Planned start Mar 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000029798.